ReviewCurrent treatment options in oncology2019

The Role of Angiogenesis Inhibitors in the Era of Immune Checkpoint Inhibitors and Targeted Therapy in Metastatic Non-Small Cell Lung Cancer.

Kirstin Perdrizet et al.PubMed ↗Publisher ↗

No numbers read from the abstract.